Whole-genome approach implicates <it>CD44 </it>in cellular resistance to carboplatin

<p>Abstract</p> <p>Carboplatin is a chemotherapeutic agent used in the management of many cancers, yet treatment is limited by resistance and toxicities. To achieve a better understanding of the genetic contribution to carboplatin resistance or toxicities, lymphoblastoid cell lines...

Full description

Bibliographic Details
Main Authors: Shukla Sunita J, Duan Shiwei, Wu Xiaolin, Badner Judith A, Kasza Kristen, Dolan M
Format: Article
Language:English
Published: BMC 2009-01-01
Series:Human Genomics
Subjects:
Online Access:http://www.humgenomics.com/content/3/2/128

Similar Items